about
Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathway.Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.Gankyrin as a potential therapeutic target for cancer.AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.Expression of the β3 subunit of Na+/K+-ATPase is increased in gastric cancer and regulates gastric cancer cell progression and prognosis via the PI3/AKT pathway.Sonic Hedgehog Signaling in Thyroid Cancer.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.FGF21 inhibitor suppresses the proliferation and migration of human umbilical vein endothelial cells through the eNOS/PI3K/AKT pathway.In Vitro Antitumor Activity of Aloperine on Human Thyroid Cancer Cells through Caspase-Dependent Apoptosis.The impact of phosphatases on proliferative and survival signaling in cancer.S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution.Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged MiceMKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway
P2860
Q37393385-E78A1196-DDF9-4FF9-A36E-62EF6A30CC71Q37687319-8EC962A9-D467-4ED3-8F84-E620766B677DQ38719594-E23765B0-1F1A-4E68-9D07-9ED23C15C5F9Q38726299-A0C99121-AFAB-41FE-A87F-DD08FAAF2353Q39002801-43E63176-367C-49E3-9D96-499AB618D11FQ39116011-59C39905-B39C-4CB5-BE15-6C1CED19C4CAQ39319386-691B9F00-B5F2-4F77-BE27-0F71E350DEE0Q40154948-4A5F65B6-8669-4B64-BC5C-29BFD3B7B39EQ45144926-F16CF042-1ACB-4DE1-AF89-681D4F1C3F58Q46170145-D21B6651-3665-4DC1-B5F6-0470DAA74F1CQ47128709-9679D2D6-F318-43FE-A778-D7AB552F69A0Q47220838-F6559ED7-741B-4131-9E9B-71B0D0B2BE35Q48182708-0EEAE4C4-83C0-49AB-AA17-96087D9017DAQ54112403-42204E00-0B75-4931-BB60-1A96D362D7D7Q54120638-2F82743B-BD82-4518-8147-1C4625EF3949Q55004058-4AF66817-5EA2-49F0-847E-B83CEFE8BFF2Q55068347-B8DD0045-D6E2-43BF-9BD0-83B983914B1FQ58764136-3C577673-0F2C-4FFE-A8B0-2B1189D71D52Q58786364-2ED22783-46DB-4EC2-9725-A355E0163432
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@ast
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@en
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@nl
type
label
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@ast
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@en
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@nl
prefLabel
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@ast
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@en
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@nl
P2860
P356
P1476
The PI3K/Akt Pathway in Tumors of Endocrine Tissues
@en
P2093
Angela Hague
Helen Louise Robbins
P2860
P356
10.3389/FENDO.2015.00188
P407
P577
2015-01-01T00:00:00Z